摘要:
It is intended to provide a method of predicting the recurrence after treating liver cancer. A method of predicting the recurrence after treating liver cancer characterized by assaying GPC3 in a test sample with the use of anti-GPC3 antibody.
摘要:
An object of the present invention is to provide a radioactive metal anti-cadherin antibody which is highly accumulated specifically in cancer tissue. Another object is to provide a cancer therapeutic agent having high anti-cancer effect and safety and a cancer diagnostic agent. The radioactive metal-labeled anti-cadherin antibody which is obtained by binding a radioactive metallic element to an anti-cadherin antibody via a metal-chelating reagent.